APPENDICES. A systematic review and economic model of the ...
APPENDICES. A systematic review and economic model of the ...
APPENDICES. A systematic review and economic model of the ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Study Intervention Participants Outcomes<br />
Core symptoms<br />
IOWA Conners’ Rating Scale: inattention,<br />
impulsivity <strong>and</strong> overactivity (teacher, parent,<br />
counsellor)<br />
Abbreviated Conners’ Rating Scale (teacher,<br />
parent)<br />
SKAMP rating scale: attention (teacher)<br />
Arm 1<br />
Placebo plus non-drug intervention<br />
Administered 3 times daily (7.30<br />
a.m., 11.30 a.m., 3.30 p.m.);<br />
behavioural programme<br />
incorporating parent training, teacher<br />
consultation <strong>and</strong> point systems<br />
(Administered by parent, school<br />
personnel <strong>and</strong> study staff)<br />
References<br />
Pelham et al., 2001; 82<br />
Pelham et al., 2000; 316<br />
Pelham et al., 2000317 <strong>and</strong> Connor, 2002318 Source<br />
Updated search<br />
Co-existent problems<br />
IOWA Conners’ Rating Scale:<br />
oppositional–defiant behaviour (teacher,<br />
parent, counsellor)<br />
SNAP Rating Scale: Peer Relations (teacher)<br />
Classroom Observation Code for Attention<br />
Deficit Disorders: observed on-task<br />
behaviour, observed disruptive behaviour<br />
(independent observers)<br />
Rule violations (teacher)<br />
Negative behaviours: teasing, interrupting,<br />
complaining (counsellors)<br />
SKAMP rating scale: deportment (teacher)<br />
Inclusion criteria<br />
1. Age 6–12 years<br />
2. Diagnosis <strong>of</strong> DSM-IV criteria ADHD (any subtype)<br />
3. Required to be medicated with MPH on entry to <strong>the</strong> study<br />
<strong>and</strong> must have been receiving stable dose for at least 4<br />
weeks before <strong>the</strong> beginning <strong>of</strong> <strong>the</strong> study<br />
4. No presence <strong>of</strong> medical condition that would contraindicate<br />
<strong>the</strong> use <strong>of</strong> stimulant medication<br />
5. No presence <strong>of</strong> any physical condition or severe learning<br />
difficulty that would interfere with participation in <strong>the</strong><br />
laboratory classroom assessment (e.g. IQ